跳至主要内容
临床试验/CTRI/2024/07/071465
CTRI/2024/07/071465尚未招募Unknown

A Prospective randomized study to compare the incidence of hematological toxicities between bone marrow sparing - intensity modulated radiotherapy and conventional intensity modulated radiotherapy in treatment of carcinoma of uterine cervix. - NI

Sri Venkateswara Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Carcinoma cervix of International Federation of Gynaecologist and Obstetrician (FIGO) Stage IB1 – IVA.
  • Patients of age group 18 years and older.
  • Patients with Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
  • Patients with Hb more than 10 g/dl, TC - more than 4000 cells/cu.mm, PLT - more than 1.5 lakh/cu.mm.
  • Patients who has given approved informed consent.

排除标准

  • Patients with ECOG performance status of 3-4.
  • Patients with distant metastasis.
  • Patients with prior EBRT and/or Brachytherapy to pelvis.
  • Pregnant women and lactating mothers.

研究者

相似试验